Analysis of therapeutic effect of radical prostatectomy plus individualized treatment of high-risk prostate cancer
刘定益,楚晨龙,周燕峰,王健,夏维木,王名伟,赵晨晖,张翀宇,邵远,唐崎,俞家顺,李文敏,周文龙
DOI: https://doi.org/10.3969/j.issn.1009-8291.2015.011.007
2015-01-01
Abstract:ABSTRACT:Objective To explore the therapeutic effect of retropubic radical prostatectomy (RRP) combined with indi‐vidualized treatment of endocrine and local external beam radiotherapy for 94 cases of high risk prostate cancer .Methods A total of 94 cases were diagnosed as high‐risk prostate cancer according to the D'Amico and CUA Guidelines .Of them 70 cases of T3a -T3b stage received 3‐month neoadjuvant thormonal therapy .In the procedure of RRP ,anterior Denonvillier fascia fat , bulky prostate ,and bilateral NBV were removed .The extended lymph nodes dissection was performed when lymph nodes me‐tastasis was suspected in 49 cases .Other 45 patients had RRP and local lymphadenectomy according to Walsh Method .The as‐sisted 6‐month thormonal therapy or local external beam radiotherapy were given to patients of stage≥pT3a ,Gleason≥8 ,with lymph nodes metastasis and positive surgical margin .The mean follow‐up was (66 .22 ± 40 .00)months .The operation time ,in‐traoperative blood loss ,peri‐operative complications ,numbers and time of biochemical recurrence and 5‐years survival rate were analyzed .Results In the 70 cases of high‐risk prostate cancer ,the PSA level was (46 .45 ± 36 .45)ng/mL and reduced to (1 .02 ± 1.15)ng/mL after 3‐month of neoadjuvant thormonal therapy (P<0 .01) .The mean operation time was (178 .30 ± 29 .67)min ,and the mean blood loss was (539 .90 ± 351 .46)mL .The 19 cases diagnosed to be cT3a before operation improved to be PT2c after operation .The complications included anastomotic leakage in 2 cases ,lymphatic fistula in 2 cases ,incontinence in 6 cases ,of anastomotic stricture in 1 case .Biochemical recurrence occurred in 35 cases .The 5‐year overall survival rate and tumor‐specific survival rate was 94 .2% and 96 .2% ,respectively .Conclusion The high‐risk prostate cancer patients could benefit more from retropubic radical prostatectomy assisted by thormonal therapy or external beam radiotherapy .